In this Issue:
U300 vs. U100 glargine in type 2 diabetes
Liraglutide in MDI-treated type 2 diabetes
Polyclonal regulatory T-cell immunotherapy in type 1 diabetes
Routine use of CGM in diabetes
Nonresuspended NPH insulin alters pharmacokinetics/ pharmacodynamics
Paclitaxel- vs. everolimus-eluting stents in diabetes
Baby boys increase mothers’ gestational diabetes risk
Caesarean does not affect offspring’s type 1 diabetes risk
Insulin dose and CV mortality in ACCORD
Omarigliptin for type 2 diabetes
Please login below to download this issue (PDF)